Epiclor Inj 1mg/mL 1 mg Solution is a Health Canada–registered veterinary drug (DIN 00654590) held by Rafter 8 Products Inc, containing Epinephrine Hydrochloride. Health Canada lists its status as Dormant (status date 18 Jun 2026). Nexara Health has matched 359 registrations of Epinephrine Hydrochloride across 30 other regulated markets, 3 of them in the same strength and dosage form.
Health Canada registration
| DIN | 00654590 |
|---|---|
| Brand name | Epiclor Inj 1mg/mL |
| Active ingredient | Epinephrine Hydrochloride |
| Strength | 1 mg |
| Dosage form | Solution |
| Route | Intramuscular ; Subcutaneous |
| Company | Rafter 8 Products Inc |
| Status | Dormant — 18 Jun 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Marketed | Dormant |
| 2026-09-03 | Status | Marketed | Dormant |
Epinephrine Hydrochloride registered in other markets
359 registrations of the same molecule in 30 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | EURneffy | ALK-Abello A/S | 1 mg/dosis | næsespray, opløsning i enkeltdosisbeholder | Central | Laegemiddelstyrelsen |
| Finland | EURneffy | ALK-Abello A/S | 1 mg | nenäsumute, liuos, kerta-annospakkaus | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Ireland | EURneffy 1 mg nasal spray, solution in single-dose container | ALK-Abello A/S | Nasal spray, solution in single-dose container | Unknown | HPRA | |
| Austria | EpiPen 300 mcg Inj.lsg. Fertigpen | — | 1St | yellow box | eEKO (Erstattungskodex) | |
| Austria | EpiPen Junior 150 mcg Inj.lsg. Fertigpen | — | 1St | yellow box | eEKO (Erstattungskodex) | |
| Austria | Jext 150 mcg Inj.lsg. Fertigpen | — | 1St | yellow box | eEKO (Erstattungskodex) | |
| Austria | Jext 300 mcg Inj.lsg. Fertigpen | — | 1St | yellow box | eEKO (Erstattungskodex) | |
| Bolivia | Epinefrina (Adrenalina) | — | 1 mg/ml | Inyectable | LINAME (formulary) | |
| Bulgaria | Adrenaline Sopharma | Софарма АД | 1 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Anapen | Lincoln Medical Limited | 300 micrograms/0.3 ml solution for injection in pre-filled siringe | инжекционен разтвор в предварително напълнена спринцовка | По лекарско предписание | BDA |
| Bulgaria | Anapen Junior | Lincoln Medical Limited | 150 micrograms in 0.3 ml solution for injection in pre-filled siringe | инжекционен разтвор в предварително напълнена спринцовка | По лекарско предписание | BDA |
| Bulgaria | EpiPen N | Viatris Healthcare Limited | EpiPen N 150 micrograms solution for injection in pre-filled pen | инжекционен разтвор в предварително напълнена спринцовка | По лекарско предписание | BDA |
| Bulgaria | EpiPen N Junior | Viatris Healthcare Limited | EpiPen N Junior 150 micrograms solution for injection in pre-filled pen | инжекционен разтвор в предварително напълнена спринцовка | По лекарско предписание | BDA |
| Bulgaria | Jext | ALK-Abello A/S | 150 micrograms solution for injection in pre-filled pen | инжекционен разтвор в предварително напълнена спринцовка | По лекарско предписание | BDA |
| Bulgaria | Jext | ALK-Abello A/S | 150 micrograms solution for injection in pre-filled pen | инжекционен разтвор в предварително напълнена спринцовка | По лекарско предписание | BDA |
| Croatia | adrenalin (epinefrin) | — | HZZO | |||
| Croatia | EpiPen | Viatris Hrvatska d.o.o. | otop. za inj., autoinjektor 1x2 mg/2 ml (doza 0,3 mg/0,3 ml) | R | HZZO | |
| Croatia | EpiPen Jr | Viatris Hrvatska d.o.o. | otop. za inj., autoinjektor 1x1 mg/2 ml (doza 0,15 mg/0,3 ml) | R | HZZO | |
| Czech Republic | Adrenalin Bradex | — | 1MG/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Adrenalin L��Iva | — | 1MG/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Adrenaline Accord | — | 0,1MG/ML | Inj Sol Isp | R | SUKL DLP |
| Czech Republic | Anapen | — | 300MCG/0,3ML | Inj Sol Isp | R | SUKL DLP |
| Czech Republic | Anapen Junior | — | 150MCG/0,3ML | Inj Sol Isp | R | SUKL DLP |
| Czech Republic | Epipen | — | 300MCG | Inj Sol Pep | R | SUKL DLP |
| Czech Republic | Epipen Jr. | — | 150MCG | Inj Sol Pep | R | SUKL DLP |
| Czech Republic | Eurneffy | — | 1MG | Nas Spr Sol Mdc | R | SUKL DLP |
| Denmark | Adrenalin "2care4" | 2care4 ApS | 1 mg/ml | injektionsvæske, opløsning | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Adrenalin "Aguettant" | Laboratoire Aguettant | 1 mg/ml | injektionsvæske, opløsning i fyldt injektionssprøjte | MRP | Laegemiddelstyrelsen |
| Denmark | Adrenalin "Aguettant" | Laboratoire Aguettant | 0,1 mg/ml | injektionsvæske, opløsning i fyldt injektionssprøjte | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Adrenalin "Bradex" | Orifarm A/S | 1 mg/ml | injektionsvæske, opløsning | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Adrenalin "Bradex" | Bradex S.A. | 1 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Adrenalin "Epione Medicine" | Epione Medicine ApS | 1 mg/ml | injektionsvæske, opløsning | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Adrenalin "Ethypharm" | Ethypharm | 1 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Dominican Republic | Epinefrina | Laboratorios Arsal,S. A. De C.v., El Salvador | Registered | MISPAS | ||
| European Union (EMA) | Eurneffy | ALK-Abelló A/S | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Neffy | Ars Pharmaceuticals Irl Limited | Application withdrawn | EMA centrally authorised | ||
| Finland | Adrenaliinilanka/Adr Tråd | Astra Alab Ab | 0.1 mg/cm | lanka | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Adrenalin | Evolan Pharma AB | 1 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Adrenalin | Evolan Pharma AB | 0.1 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Adrenalin | Medica | 1 mg/ml | injektioneste | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Adrenalin Aguettant | Laboratoire Aguettant | 1 mg/ml | injektioneste, liuos, esitäytetty ruisku | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Adrenalin Aguettant | Laboratoire Aguettant | 0.1 mg/ml | injektioneste, liuos, esitäytetty ruisku | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Adrenalin Ethypharm | Ethypharm | 1 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Greece | Adrenaline Injection/Demo Inj.sol 1mg/mL Btx50ampx1ml | Demo Abee | reimbursed | MoH deltio timwn | ||
| Greece | ADRENALINE/ARITI INJ.SOL 1MG/ML AMP BTx5 (AMP x1 ML) (Σκουρόχρωμες υάλινες φύσιγγες ) (ύαλος τυπου Ι)) | Αρητη A.e. | reimbursed | MoH deltio timwn | ||
| Greece | ANAPEN INJ.SOL 150MCG/0,3ML PF.SYR BTx2PF.SYR.x0,3ML | Allertec Hellas A.e. | reimbursed | MoH deltio timwn | ||
| Greece | ANAPEN INJ.SOL 300MCG/0,3ML PF.SYR. BTx2PF.SYR.x0,3ML | Allertec Hellas A.e. | reimbursed | MoH deltio timwn | ||
| Iceland | Adrenalin | Parlogis - óskráð lyf | 1 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Adrenalin | Parlogis - óskráð lyf | 0,1 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Adrenalin | Parlogis - óskráð lyf | 0,1 mg | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Adrenalin | Parlogis - óskráð lyf | 1 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Adrenalin Mylan | Viatris Limited | 1 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Adrenalin Sintetica án rotv. | Parlogis - óskráð lyf | 1 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | EpiPen | Viatris ApS | 0,3 mg/sk | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | EpiPen Junior | Viatris ApS | 0,15 mg/sk | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Ireland | Adrenaline (Epinephrine) 1 mg/10 ml (1:10,000) Solution for Injection in Pre-Filled Syringe | Laboratoire Aguettant | Solution for injection in pre-filled syringe | Marketed | HPRA | |
| Ireland | Anapen 300 micrograms in 0.3 ml solution for injection in a pre-filled syringe | Bioprojet Pharma | Solution for injection in pre-filled syringe | Marketed | HPRA | |
| Ireland | Anapen 500 micrograms/0.3 ml solution for injection in a pre-filled syringe | Bioprojet Pharma | Solution for injection in pre-filled syringe | Marketed | HPRA | |
| Ireland | Anapen Junior 150 micrograms in 0.3 ml solution for injection in a pre- filled syringe | Bioprojet Pharma | Solution for injection in pre-filled syringe | Marketed | HPRA | |
| Ireland | EpiPen 300 micrograms solution for injection in pre-filled pen | Viatris Healthcare Limited | Solution for injection in pre-filled pen | Marketed | HPRA | |
| Ireland | Epipen Evo 300 microgram solution for injection in pre-filled pen | Viatris Healthcare Limited | Solution for injection in pre-filled pen | Not marketed | HPRA | |
| Ireland | Epipen Evo Junior 150 microgram solution for injection in pre-filled pen | Viatris Healthcare Limited | Solution for injection in pre-filled pen | Not marketed | HPRA | |
| Lebanon | Adrenaline 1 mg I.v. | Alfa Laboratoires S.A.L. | 1mg/ml | Injectable solution | B | MoPH |
| Luxembourg | ANAPEN SOL.INJ. 0,15 mg / 0,3 mL 1*2 ser.préremp. | — | RR | CNS liste positive | ||
| Luxembourg | ANAPEN SOL.INJ. 0,3 mg / 0,3 mL 1*2 ser.préremp. | — | RR | CNS liste positive | ||
| Luxembourg | EURneffy SOL.PULV.NAS.UNI 2 mg 1*2 récipients 0,1 mL | — | RR | CNS liste positive | ||
| Luxembourg | FASTJEKT Junior SOL.INJ. 0,15 mg / 0,3 mL 1*1 ser.préremp. 2 ml | — | RR | CNS liste positive | ||
| Luxembourg | FASTJEKT SOL.INJ. 2,05 mg / 2,05 mL 1*1 stylo préremp. 2 mL | — | RR | CNS liste positive | ||
| Luxembourg | JEXT-150MCG/0,15ML SOL.INJ. 150 mcg / 0,15 mL 1*1 stylo préremp. 0,15 mL | — | RR | CNS liste positive | ||
| Luxembourg | JEXT-300MCG/0,30ML SOL.INJ. 300 mcg / 0,3 mL 1*1 stylo préremp. 0,3 mL | — | RR | CNS liste positive | ||
| MA | Adrenaline 0,25 mg | — | 0.25 MG | Solution Injectable | G | CNOPS liste des medicaments |
| MA | Adrenaline 0,25 mg | — | 0.25 MG | Solution Injectable | G | CNOPS liste des medicaments |
| MA | Adrenaline 0,50 mg | — | 0.5 MG | Solution Injectable | G | CNOPS liste des medicaments |
| MA | Adrenaline 0,50 mg | — | 0.5 MG | Solution Injectable | G | CNOPS liste des medicaments |
| MA | Adrenaline 1 mg | — | 1 MG | Solution Injectable | G | CNOPS liste des medicaments |
| MA | Adrenaline 1 mg | — | 1 MG | Solution Injectable | G | CNOPS liste des medicaments |
| Malaysia | Pharmaniaga Adrenaline 1mg/mL Injection (1ml Glass Ampoule) | Pharmaniaga Lifescience Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malta | Adrenaline (Epinephrine) Injection BP 1 in 1000 | JV Healthcare Limited | Injection | Authorised | Medicines Authority | |
| Malta | Anapen 300 micrograms in 0.3ml solution for injection in a pre-filled syringe | Bioprojet Pharma | Solution For Injection In A Pre-Filled Syringe | Withdrawn | Medicines Authority | |
| Malta | Anapen Junior 150 micrograms in 0.3ml solution for injection in a pre-filled syringe | Bioprojet Pharma | Solution For Injection In A Pre-Filled Syringe | Withdrawn | Medicines Authority | |
| Malta | EpiPen 300 microgram solution for injection in pre-filled pen | Viatris Healthcare Limited | Solution For Injection In A Pre-Filled Pen | Authorised | Medicines Authority | |
| Malta | EpiPen Junior 150 microgram solution for injection in pre-filled pen | Viatris Healthcare Limited | Solution For Injection In A Pre-Filled Pen | Authorised | Medicines Authority | |
| Malta | Jext 150 micrograms solution for injection in pre-filled pen | JV Healthcare Limited | Solution For Injection In A Pre-Filled Pen | Authorised | Medicines Authority | |
| Netherlands | Adrenaline Accord 0,1 mg/ml, oplossing voor injectie in een voorgevulde spuit | Accord Healthcare B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Adrenalinum | BOIRON (Messimy) | 6 DH t/m 60 DH#3 CH t/m 200 CH#6 K t/m 100.000 K#2 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Adrenalinum | BOIRON (Messimy) | 6 DH t/m 60 DH#3 CH t/m 200 CH#6 K t/m 100.000 K#2 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Anapen junior, oplossing voor injectie 0,15 mg/dosis | Bioprojet Pharma | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Anapen, oplossing voor injectie 0,3 mg/dosis | Bioprojet Pharma | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | EpiPen 300 microgram/dosis, oplossing voor injectie in een voorgevulde pen 1 mg/ml | Viatris Healthcare Limited | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | EpiPen 300 microgram/dosis, oplossing voor injectie in een voorgevulde pen 1 mg/ml | Euro Registratie Collectief B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | EpiPen junior 150 microgram/dosis, oplossing voor injectie in een voorgevulde pen 0,5 mg/ml | Medcor Pharmaceuticals B.V. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Norway | Adrenalin Aguettant inj, oppl 0,1 mg/ml | Laboratoire Aguettant | 10 x 10 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Adrenalin Aguettant inj, oppl 1 mg/ml | Laboratoire Aguettant | 10 x 5 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Adrenalin base NAF kons til inj oppl 1 mg/ml | Sykehusapoteket Oslo, Rikshospitalet | 10 x 5 | Konsentrat til injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Adrenalin bradex inj, oppl 1 mg/ml | Bradex | 10 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Adrenalin Ethypharm inj, oppl 1 mg/ml | Orifarm AS | 10 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Adrenalin Ethypharm inj, oppl 1 mg/ml | Ethypharm (1) | 10 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Adrenalin inj, oppl 0,1 mg/ml | Evolan Pharma AB | 10 x 5 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Adrenalin inj, oppl 1 mg/ml | Evolan Pharma AB | 10 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Poland | Adrenalina Aguettant | Laboratoire Aguettant | 1 mg/10 ml | Roztwór do wstrzykiwań w ampułko-strzykawce | Bezterminowe | URPL RPL |
| Poland | Adrenalina Noridem | Noridem Enterprises Ltd. | 1 mg/ml | Roztwór do wstrzykiwań | 2030-08-04 | URPL RPL |
| Poland | Adrenalina WZF | Zakłady Farmaceutyczne POLPHARMA S.A. | 300 mcg/0,3 ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Adrenalina WZF 0,1% | Zakłady Farmaceutyczne POLPHARMA S.A. | 1 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Jext | Alk-Abello A/S | 300 mcg | Roztwór do wstrzykiwań we wstrzykiwaczu | Bezterminowe | URPL RPL |
| Poland | Jext | Alk-Abello A/S | 150 mcg | Roztwór do wstrzykiwań we wstrzykiwaczu | Bezterminowe | URPL RPL |
| Saudi Arabia | Adijet | — | 1 | Inactive | SFDA | |
| Saudi Arabia | ADRENALINE 0.1mg/mL | — | 1 | Inactive | SFDA | |
| Saudi Arabia | Adrenaline 0.1mg/mL Injection | — | 0.1 | Inactive | SFDA | |
| Saudi Arabia | Adrenaline 1:1000 Inj | — | 1 | Inactive | SFDA | |
| Saudi Arabia | Adrenaline HCl 1mg-mL Amp | — | 1 | Inactive | SFDA | |
| Saudi Arabia | Adrenaline/Epinephrine Inj 1:1000 Injection | — | 1 | Inactive | SFDA | |
| Saudi Arabia | Aronep | — | 1 | Inactive | SFDA | |
| Saudi Arabia | DILUTE ADRENALINE (Epinephrine) 1:10,000 solution for injection | — | 100 | Inactive | SFDA | |
| Singapore | Adrenaline Aguettant Solution For Injection In Pre-Filled Syringe 0.1 mg/mL | Intega Pte Ltd | 0.1 mg/ml | Injection, Solution | Prescription Only | HSA |
| Singapore | Adrenaline Injection 1:1000 | Atlantic Pharmaceutical (S) Pte Ltd | 1 mg/ml | Injection | Prescription Only | HSA |
| Singapore | Artinibsa 4% With Epinephrine Solution For Injection 1:100000 | Fondaco Pte Ltd | 0.01mg&&40.00 mg | Injection, Solution | Prescription Only | HSA |
| Singapore | EpiPen (Epinephrine) Auto-Injector 0.3mg/dose (1mg/ml) | Good Pharmaceutical Pte. Ltd. | 1 mg/ml | Injection | Prescription Only | HSA |
| Singapore | EpiPen Junior (Epinephrine) Auto-Injector 0.15mg/dose (0.5mg/ml) | Good Pharmaceutical Pte. Ltd. | 0.5 mg/ml | Injection | Prescription Only | HSA |
| Slovakia | Adrenalin Bradex 1 mg/ml injekčný roztok | Bad | sol inj 10x1 ml (amp.skl.jantárová) | 1G | MZ SR kategorizacia | |
| Slovakia | Jext 300 mikrogramov | Xll-Dk | sol ira 1x0,30 ml/300 µg (pero inj.napl.) | O | MZ SR kategorizacia |
See every manufacturer of Epinephrine Hydrochloride worldwide →
Regulator price references for Epinephrine Hydrochloride
Published list or reimbursement prices for Epinephrine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | EpiPen 300 mcg Inj.lsg. Fertigpen | 0.3mg | 1St | 60.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | EpiPen Junior 150 mcg Inj.lsg. Fertigpen | 0.15mg | 1St | 60.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Jext 300 mcg Inj.lsg. Fertigpen | 0.3mg | 1St | 60.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Jext 150 mcg Inj.lsg. Fertigpen | 0.15mg | 1St | 60.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Greece | Adrenaline Injection/Demo Inj.sol 1mg/mL Btx50ampx1ml | 1mg/1ml | 0.89 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ADRENALINE/ARITI INJ.SOL 1MG/ML AMP BTx5 (AMP x1 ML) (Σκουρόχρωμες υάλινες φύσιγγες ) (ύαλος τυπου Ι)) | 1mg/1ml | 0.89 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ANAPEN INJ.SOL 300MCG/0,3ML PF.SYR. BTx2PF.SYR.x0,3ML | 0.3mg/0.3ml | 55.99 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ANAPEN INJ.SOL 150MCG/0,3ML PF.SYR BTx2PF.SYR.x0,3ML | 0.15mg/0.3ml | 55.99 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Adrenalin | 0.1mg | dæla | 2,948.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Adrenalin Sintetica án rotv. | 1mg/1ml | lykjur | 3,994.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Adrenalin Mylan | 1mg/1ml | gl-lyk | 4,470.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Jext | 0.15mg | pakki | 5,166.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Jext | 0.3mg | pakki | 5,166.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Adrenalin | 1mg/1ml | lykjur | 5,210.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | EpiPen Junior | 0.15mg | pakki | 6,671.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | EpiPen | 0.3mg | pakki | 7,705.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Adrenalin | 1mg/1ml | lykjur | 8,877.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Adrenalin | 0.1mg/1ml | lykjur | 26,022.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Lebanon | Adrenaline 1 mg I.v. | 1mg/1ml | 100 x 1ml | 25.02 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Luxembourg | JEXT-300MCG/0,30ML SOL.INJ. 300 mcg / 0,3 mL 1*1 stylo préremp. 0,3 mL | 0.3mg/0.3ml+0.3mg/0.3ml | 45.32 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | JEXT-150MCG/0,15ML SOL.INJ. 150 mcg / 0,15 mL 1*1 stylo préremp. 0,15 mL | 0.15mg/0.15ml+0.15mg/0.15ml | 45.32 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | ANAPEN SOL.INJ. 0,15 mg / 0,3 mL 1*2 ser.préremp. | 0.15mg/0.3ml | 66.82 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | ANAPEN SOL.INJ. 0,3 mg / 0,3 mL 1*2 ser.préremp. | 0.3mg/0.3ml | 66.82 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | FASTJEKT SOL.INJ. 2,05 mg / 2,05 mL 1*1 stylo préremp. 2 mL | 2.05mg/2.05ml | 92.75 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | FASTJEKT Junior SOL.INJ. 0,15 mg / 0,3 mL 1*1 ser.préremp. 2 ml | 0.15mg/0.3ml | 92.75 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | EURneffy SOL.PULV.NAS.UNI 2 mg 1*2 récipients 0,1 mL | 0.1ml+2mg | 254.83 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| MA | Adrenaline 0,25 mg | 0.25mg | 1 BOITE 10 AMPOULE INJECTABLE | 18.25 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Adrenaline 0,50 mg | 0.5mg | 1 BOITE 10 AMPOULE INJECTABLE | 20.60 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Adrenaline 1 mg | 1mg | 1 BOITE 10 AMPOULE INJECTABLE | 21.20 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Adrenaline 0,25 mg | 0.25mg | 1 BOITE 100 AMPOULE INJECTABLE | 167.40 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Adrenaline 0,50 mg | 0.5mg | 1 BOITE 100 AMPOULE INJECTABLE | 188.60 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Adrenaline 1 mg | 1mg | 1 BOITE 100 AMPOULE INJECTABLE | 194.70 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| Norway | Adrenalin Ethypharm | 1mg/1ml | 1 ml | 456.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Adrenalin Ethypharm | 1mg/1ml | 1 ml | 456.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Jext | 0.15 ml | 580.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Jext | 0.3 ml | 580.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | EpiPen | 1 dose | 696.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | EpiPen Jr | 1 dose | 696.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Adrenalin Martindale Pharma | 0.1mg/1ml | 10 ml | 1,039.30 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | EpiPen Jr | 1 dose | 1,355.90 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | EpiPen | 1 dose | 1,355.90 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 | |
| Norway | Adrenalin Aguettant | 0.1mg/1ml | 10 ml | 1,868.40 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Eurneffy | 2mg | 0.1 ml | 3,284.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Adrenalin Aguettant | 1mg/1ml | 5 ml | 8,068.30 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Saudi Arabia | Adrenaline 1:1000 Inj | 12.45 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Adrenaline/Epinephrine Inj 1:1000 Injection | 19.15 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Adrenaline HCl 1mg-mL Amp | 1mg | 22.65 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | EPINEPHRINE INJ 1:10000 ABBOJECT GLASS SYRINGE (18 G x 3 1/2") | 18000mg | 28.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Epinephrine Inj | 32.60 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Adrenaline 0.1mg/mL Injection | 0.1mg/1ml | 50.45 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Aronep | 80.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Adijet | 80.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | DILUTE ADRENALINE (Epinephrine) 1:10,000 solution for injection | 243.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | EpiPen 300 mcg per 0.3 ml | 0.3mg+0.3ml | 363.00 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | EpiPen 150 mcg per 0.3 ml | 0.15mg+0.3ml | 363.00 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Jext | 363.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Jext | 363.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | ADRENALINE 0.1mg/mL | 0.1mg/1ml | 504.50 SAR | public | SFDA | 2026-09-01 | |
| Slovakia | Adrenalin Léčiva | 1mg+1ml | sol inj 5x1 ml/1 mg (amp.skl.) | 4.43 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | Adrenalin Bradex 1 mg/ml injekčný roztok | 1ml | sol inj 10x1 ml (amp.skl.jantárová) | 8.85 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | Jext 300 mikrogramov | 0.3mg+0.3ml | sol ira 1x0,30 ml/300 µg (pero inj.napl.) | 35.64 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | Jext 150 mikrogramov | 0.15mg+0.15ml | sol ira 1x0,15 ml/150 µg (pero inj.napl.) | 36.48 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | EpiPen | 0.3mg+2ml | sol inj 1x2 ml/0,3 mg (amp.inj.skl.) | 44.01 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | EpiPen Jr. | 0.15mg+2ml | sol inj 2x2 ml/0,15 mg (amp.inj.skl.) | 89.13 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | EpiPen | 0.3mg+2ml | sol inj 2x2 ml/0,3 mg (amp.inj.skl.) | 93.96 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| South Africa | Adrenotone | 1mg/1ml | 1 | 24.76 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Pharma-Q Adrenaline Injection 1mg/ml | 1mg/1ml | 10 | 43.27 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Adrenaline (Epinephrine) 1 mg/1 ml (1:1 000) Fresenius | 1mg/1ml | 1 | 113.92 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Epipen Junior Auto-Injector | 0.15mg/0.3ml | 0.3 | 1,123.39 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Epipen | 1mg/1ml | 1 | 1,123.50 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Epipen Junior Auto-Injector | 0.15mg/0.3ml | 0.3 | 2,246.78 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Epipen | 1mg/1ml | 1 | 2,247.00 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | ADRENALIN S.A.L.F. 1mg/ml | 1mg/1ml | 5’s (1 ml Ampoules x 5) | 31.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Jext® 300 Micrograms | 1 Pre-filled Pen (0.3ml) | 256.00 AED | public | EDE | 2026-08-31 | |
| United Arab Emirates | Jext® 150 Micrograms | 1 Pre-filled Pen (0.15ml) | 256.00 AED | public | EDE | 2026-08-31 | |
| United Arab Emirates | ADREnaline Aguettant 1mg/1ml - Sulfite free (PFS) | 1mg/1ml | 10 Pre-filled Syringes (5 mL) | 1,486.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Epiclor Inj 1mg/mL (DIN 00654590) marketed in Canada?
No. Health Canada lists DIN 00654590 as Dormant as of 18 Jun 2026.
Who holds the Canadian licence for this product?
Rafter 8 Products Inc is the company of record in the Health Canada Drug Product Database.
Is Epinephrine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 359 registrations in 30 other markets, including 3 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00654590, status date 2026-06-18; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, MZ SR kategorizacia, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00654590, status date 2026-06-18; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, MZ SR kategorizacia, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, SFDA.
Health Canada Drug Product Database (DPD), DIN 00654590, status date 2026-06-18; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, MZ SR kategorizacia, NPRA, SFDA, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.